Tweet
Any programs for analyzing solexa transcriptome (alternative splicing) ?
-
-
Do you have a reference transcriptome?Originally posted by baohua100 View Post
If so, does it contain alternatively spliced sequences? -
we have reference transcriptome 。 but one gene one transcript sequence
there are no alternative splicing informationComment
-
I wonder if Solexa reads, say 50bp can identify alternative splicing when you don't have a reference genome. How can we tell the alignment software to map the reads so we can find splice variant?
Alternative splicing has been reported using 454 reads. The longer reads is probably an advantage. Anyone has done similar work using Solexa reads?Comment
-
Tophat does a really nice job mapping splice junctions without a set of known splice sites. It works very well with short Solexa reads, though I presume it requires a certain degree of read depth.Comment
-
i have reads.fq (5 000 000 reads RNA-seq) genome.fa
when i use bowtie align the reads, it aligns 4 200 000 reads.
but when i use tophat align the reads, the output file accepted_hits.sam only contains 1 900 000 reads. junctions.bed file is blank.Comment
-
Gmorse from the french genoscope (PMID: 19087247). It works with short reads and does not require any reference transcriptome, as explained here. Maybe limited for very complex and dense transcriptomes though (human/mouse/etc).Originally posted by baohua100 View Post
With a reference transcriptome, if you want to assign a quantity to each splicing variant I only know about this flux capacitor. Maybe not fully stable yet. I'm sure a lot of similar projects are in progress.
(Disclaimer: I personally know these people, they are friends of mine -but don't worry, contrary to me they still work in academic research).
Much more is expected to come from the RGASP project. I'd suggest to keep an eye on this.
Then, there are commercial products that claim to address "alternative splicing", but I am curious about what they really do...
yours,
s.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment